Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates

AIDS Research and Human Retroviruses

Volumn 17, Issue 15, 2001, Pages 1405-1414

  Jansson, Marianne ^a,b   Backström, Eva ^a   Scarlatti, Gabriella ^a,c   Björndal, Åsa ^a   Matsuda, Shunji ^d   Rossi, Paolo ^b   Albert, Jan ^e   Wigzell, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DNA FRAGMENT; GLYCOPROTEIN GP 120;

ANALYTIC METHOD; ARTICLE; ASSAY; CONTROLLED STUDY; DISEASE COURSE; GENE SWITCHING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS ENVELOPE; VIRUS GENE; VIRUS ISOLATION;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, CD4; CHILD; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4;

EID: 0034755058     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201753197079     Document Type: Article

References (55)

1. Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
2. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS
3. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
4. Extensive variation of human immunodeficiency virus type 1 in vivo
5. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
6. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
7. Fidelity of HIV-1 reverse transcriptase
8. The accuracy of reverse transcriptase from HIV-1
9. Viral dynamics in human immunodeficiency virus type 1 infection
10. Heterogeneity of HIV-1 and HIV-2
11. Recombination in HIV-1
12. Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable regions
13. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
14. Identification and characterization of a neutralizing site within the second variable region of human immunodeficiency virus type 1 gp120
15. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees
16. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides
17. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
18. Induction of broadly cross-reactive cytotoxic T-cell recognizing an HIV-1 envelope determinant
19. Both the V2 and the V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with outer envelope regions in syncytium formation
20. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
21. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
22. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
23. Macrophage and T-cell line tropism of HIV-1 are determined by specific regions of the envelope gp120 gene
24. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody
25. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
26. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
27. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium inducing isolates in patients with AIDS and AIDS-related complex
28. Biological features of HIV-1 that correlate with virulence in the host
29. βreceptor as a fusion cofactor for macrophage-tropic HIV-1
30. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
31. Identification of a major co-receptor for primary isolates of HIV-1
32. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
33. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
34. HIV-1 phenotype classified by coreceptor usage
35. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
36. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection
37. HIV-1 phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay
38. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
39. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates
40. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
41. Relation of phenotype evolution of HIV-1 to envelope V2 configuration
42. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites
43. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses
44. Sequence diversity of V1 and V2 domains of gp120 from HIV-1: Lack of correlation with viral phenotype
45. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers
46. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics
47. Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype
48. Direct solid-phase sequencing of genomic and plasmid DNA using magnetic beads solid support
49. Analysis of heterogeneous viral populations by direct DNA sequencing
50. Increased frequency of abnormal gamma delta T cells in blood of patients with inflammatory bowel diseases
51. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant
52. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
53. Phenotypical heterogeneity in a panel of infectious molecular clones derived from a single individual
54. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
55. Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site